Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

We have demonstrated that the angiotensin-converting enzyme (ACE) genotype is associated with Alzheimer's disease (AD) in the Japanese population (1Hu J. Miyatake F. Aizu Y. Nakagawa H. Nakamura S. Tamaoka A. Takahashi R. Urakami K. Shoji M. Neurosci. Lett. 1999; 277: 65-67Crossref PubMed Scopu...

ver descrição completa

Na minha lista:

Detalhes bibliográficos
Principais autores:	Jianguo Hu, Akira Igarashi, Makiko Kamata, Hachiro Nakagawa
Formato:	Artigo
Idioma:	Inglês
Publicado em:	2001
Acesso em linha:	https://doi.org/10.1074/jbc.m104068200 http://www.jbc.org/article/S0021925819402937/pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados

The N‐terminal active centre of human angiotensin‐converting enzyme degrades Alzheimer amyloid β‐peptide
por: Ryutaro Oba, et al.
Publicado em: (2005)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ(1–42)) to Aβ(1–40), and Its Inhibition Enhances Brain Aβ Deposition
por: Zou, Kun, et al.
Publicado em: (2007)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
por: Assarsson, Anna, et al.
Publicado em: (2014)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
por: Anna Assarsson, et al.
Publicado em: (2014)

New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
por: Yuji Yoshiike, et al.
Publicado em: (2001)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ<sub>1–42</sub>) to Aβ<sub>1–40</sub>, and Its Inhibition Enhances Brain Aβ Deposition
por: Kun Zou, et al.
Publicado em: (2007)

Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
por: Wisniewski, Thomas, et al.
Publicado em: (2008)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
por: Abelein, Axel, et al.
Publicado em: (2015)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
por: Axel Abelein, et al.
Publicado em: (2015)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
por: Joshi, P, et al.
Publicado em: (2014)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
por: P. Joshi, et al.
Publicado em: (2013)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
por: Zou, Kun, et al.
Publicado em: (2009)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
por: Kun Zou, et al.
Publicado em: (2009)

TMPyP Inhibits Amyloid-β Aggregation and Alleviates Amyloid-Induced Cytotoxicity
por: Fan, Yujuan, et al.
Publicado em: (2017)

Regulation of Steady-state β-Amyloid Levels in the Brain by Neprilysin and Endothelin-converting Enzyme but Not Angiotensin-converting Enzyme
por: Elizabeth A. Eckman, et al.
Publicado em: (2006)

The Serpin-Enzyme Complex Receptor Recognizes Soluble, Nontoxic Amyloid-β Peptide but Not Aggregated, Cytotoxic Amyloid-β Peptide
por: Kimberly Boland, et al.
Publicado em: (1996)

TDP-43 expression influences amyloid β plaque deposition and tau aggregation
por: Davis, Stephani A., et al.
Publicado em: (2017)

TDP-43 expression influences amyloidβ plaque deposition and tau aggregation
por: Stephani A. Davis, et al.
Publicado em: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
por: Korshavn, Kyle J., et al.
Publicado em: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
por: Kyle J. Korshavn, et al.
Publicado em: (2017)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
por: Garai, Kanchan, et al.
Publicado em: (2014)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
por: Kanchan Garai, et al.
Publicado em: (2014)

Conversion of Aβ43 to Aβ40 by the successive action of angiotensin‐converting enzyme 2 and angiotensin‐converting enzyme
por: Shuyu Liu, et al.
Publicado em: (2014)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
por: Du, Wen-Jie, et al.
Publicado em: (2015)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
por: Wenjie Du, et al.
Publicado em: (2015)

Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells
por: Mikhail Matveyenka, et al.
Publicado em: (2025)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
por: Wang, Qiuming, et al.
Publicado em: (2013)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
por: Qiuming Wang, et al.
Publicado em: (2013)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
por: Hemming, Matthew L., et al.
Publicado em: (2005)

Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme
por: Larmuth, Kate M., et al.
Publicado em: (2016)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
por: Matthew L. Hemming, et al.
Publicado em: (2005)

A New Motif in the N‐Terminal of Acetylcholinesterase Triggers Amyloid‐β Aggregation and Deposition
por: Hou, Li‐Na, et al.
Publicado em: (2013)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
por: Jin, Sha, et al.
Publicado em: (2016)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
por: Sha Jin, et al.
Publicado em: (2016)

β‐Amyloid aggregation and heterogeneous nucleation
por: Srivastava, Atul K., et al.
Publicado em: (2019)

β‐Amyloid aggregation and heterogeneous nucleation
por: Atul Srivastava, et al.
Publicado em: (2019)

Aggregation and structure of amyloid β-protein
por: Kenjiro Ono, et al.
Publicado em: (2021)

Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
por: Takami Tomiyama, et al.
Publicado em: (1996)

Heparin Nanoparticles for β Amyloid Binding and Mitigation of β Amyloid Associated Cytotoxicity
por: Wang, Peng, et al.
Publicado em: (2014)

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
por: Kehoe, Patrick Gavin, et al.
Publicado em: (2016)